SATCO CAPITAL MARKETS LTD.("WINDOW TO THE WORLD OF INVESTMENT OPPORTUNITIES")

BLOGS
GO
BUDGET 2018-19
WHAT'S NEW
googlemarker
Open An Account
Secure With Us
Trade on Mobile

MARKETS & OUR SERVICES

Equity

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 484443.28 Face Value (Rs.) : 2 House : Cipla
BSE601.65-1.9 (-0.31 %)
PREV CLOSE (Rs.) 603.55
OPEN PRICE (Rs.) 609.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 307237
TODAY'S LOW / HIGH (Rs.)600.50 609.80
52 WK LOW / HIGH (Rs.)508.1 663
NSE603.500.65 (+0.11 %)
PREV CLOSE( Rs. ) 602.85
OPEN PRICE (Rs.) 608.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 603.50 (500)
VOLUME 3052143
TODAY'S LOW / HIGH(Rs.) 602.00 609.70
52 WK LOW / HIGH (Rs.)507.2 663.4
Home Markets & Our ServicesCompany ProfileSmart Quotes
BSE NSE
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1851.87
Dividend Yield(%)
0.50
TTM EPS (Rs.)
18.24
P/E Ratio
32.99
Book Value (Rs.)
175.28
Face Value (Rs.)
2
MCap (Rs. in Mn)
484443.28
Price/Earning (TTM)
24.24
Price/Sales (TTM)
4.40
Price/Book (MRQ)
3.43
PAT Margin (%)
8.88
ROCE (%)
9.34
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 022-24826951

Website : www.cipla.com

Registrars Details :

Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
21Jun Cipla, GAIL and Capital First to see s
Cipla has received final approval for its Abbreviated New Drug Applicati..
21Jun Cipla gets approval for Testosterone C
Cipla has received final approval for its Abbreviated New Drug Applicati..
21Jun Cipla moves up on getting approval for
Cipla is currently trading at Rs. 604.75, up by 1.20 points or 0.20% fro..
more
QTR Mar 18 ANNUAL 18
Net Profit2248.114685.2
Gross Profit 2716.7 19114
Operating Profit 4862.3 25304.3
Net Sales 27253.4 114448.1
more
Rs. in Millions
Abbott India (BSE)
img  7297.95 (1.99%)
M.Cap (Rs. in Cr)15507.63
Jenburkt Pharma (BSE)
img  730.50 (2.74%)
M.Cap (Rs. in Cr)335.25
Zim Laboratories (BSE)
img  309.20 (4.99%)
M.Cap (Rs. in Cr)249.21
Glenmark Pharma (BSE)
img  601.75 (1.93%)
M.Cap (Rs. in Cr)16979.47
PROMOTERS
37.21%
NON-INSTITUTION
24.69%
MUTUAL FUNDS/UTI
10.07%
FI/BANKS/INSURANCE
3.81%
FII
0.31%
GOVERNMENT
0%
more
site map
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By ●●●Accord Fintech Pvt.Ltd.
VISIT COUNT     828224